Press Releases

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)-- The international law firm Greenberg Traurig, P.A. announced that Shareholder Jon L. Swergold has been elected to the Board of Trustees of the Museum of Discovery and Science.

“The museum with its new EcoDiscovery Center is a great resource to the community and Jon is honored to be invited to serve on such a dynamic and proactive board," said Frank Brogan Jr., Co-Managing Shareholder of Greenberg Traurig’s Fort Lauderdale office and former board member of the museum. According to the museum’s website, the mission of the Museum of Discovery and Science is to provide experiential pathways to lifelong learning in science for children and adults through exhibits, programs and films.

As a commercial litigator, Jon has represented local, national and international clients in numerous jury and non-jury trials. Jon routinely litigates partnership and shareholder disputes, business fraud, banking disputes, bankruptcy matters, business torts, creditor rights and contract related issues. Jon’s broad range of experience includes representing national banks, manufacturers, real estate developers, shopping mall owners, oil and gas companies, and others in a wide range of business disputes as both plaintiff’s and defendant’s counsel. Jon was formerly a Lieutenant Commander in the United States Naval Reserve and a member of the United States Navy's Judge Advocate General's Corps. Jon received his J.D. from Brooklyn Law School and his A.B. in Political Science from Columbia University.

About Greenberg Traurig, LLP

Greenberg Traurig, LLP is an international, full-service law firm with approximately 1800 attorneys serving clients from more than 30 offices in the United States, Latin America, Europe and Asia. In the U.S., the firm has more offices than any other among the Top 10 on The National Law Journal’s 2011 NLJ 250. In Mexico, the firm operates as Greenberg Traurig, S.C., and in the U.K., as Greenberg Traurig Maher LLP. Greenberg Traurig has a strategic alliance with the independent law firm, Studio Santa Maria with offices in Milan and Rome. The firm was Chambers and Partners' USA Law Firm of the Year in 2007 and among the Top 3 in the International Law Firm of the Year at the 2009 The Lawyer Awards. For additional information, please visit www.gtlaw.com.

Greenberg Traurig, LLPMargie Garcia, 954-768-8211Garciama@gtlaw.com

Source: Greenberg Traurig, LLP

MIAMI--(BUSINESS WIRE)-- The international law firm Greenberg Traurig, PA announced today that Cory W. Eichhorn has been appointed to the Executive Committee for the Special Olympics of Miami-Dade County.

“Cory, who was just elevated to shareholder in our firm, will be a great addition to the Special Olympics Executive Committee with his legal experience and longstanding business and community contacts in South Florida,“ said Glenn E. Goldstein, Co-Managing Shareholder for Greenberg Traurig’s Fort Lauderdale office.

According to its website, the mission of Special Olympics is to provide year-round sports training and athletic competition in a variety of Olympic-type sports for children and adults with intellectual disabilities. Special Olympics Miami-Dade County was established in 1991 for children and adults in our community and now has over 3000 participants in thirteen different sports.

Eichhorn is a commercial litigator who regularly represents clients in the financial services industry including national banks, mortgage bankers, loan servicers and consumer finance companies. Eichhorn represents clients in securities fraud class actions, complex real estate disputes, and employment related litigation. He also has experience in the appellate arena, representing clients throughout Florida's appellate courts. Eichhorn received his J.D. from the University of Miami and his B.A. from the University of Florida.

Greenberg Traurig, PAMargie Garcia, 954-768-8211garciama@gtlaw.com

Source: Greenberg Traurig, PA

WASHINGTON--(BUSINESS WIRE)-- Today, the Lupus Foundation of America (LFA) announced new research grants awarded to fund critical areas of research where gaps exist in the understanding and knowledge of lupus including: pediatric lupus, cutaneous (skin) lupus, mid-to-late stage translational research, adult stem cells, and neuropsychiatric lupus, which affects the brain and nervous system. The LFA’s National Research Program: Bringing Down the Barriers, is committed to accelerating the pace of medical discovery in lupus and directing support toward promising areas of study where other public and private organizations have not focused their efforts.

Several studies this year focus on important areas of pediatric lupus research, including lupus nephritis in children, quality of life, and central nervous system involvement (CNS) in children. The LFA is the only national organization with a dedicated pediatric lupus research program. Little is known about the long-term impact of the disease on children. Childhood lupus tends to be more severe than adult-onset lupus, and children are at greater risk for life-threatening complications such as damage to their kidneys, heart, lungs, and brain.

This is the first year of funding for the Lucy Vodden Research Grant Award that was established in 2011 by the LFA and musician and LFA Global Ambassador Julian Lennon. The grant will fund the validation of a tool to evaluate the quality of life in children with lupus, allowing for more efficient and accurate self- reported health outcomes. Another significant research study this year will fund a large-scale comparison of available treatments for lupus nephritis in children, to demonstrate a standard of treatment which currently does not exist. The outcomes of the studies could have an immediate and direct impact on the care and quality of life for children with lupus.

The LFA is also funding a potentially breakthrough study that will evaluate the use of adult donor stem cells as a potential pathway for the treatment of lupus. Stem cells as therapeutics is a highly promising, but also highly controversial area of research. Some of the controversy revolves around a misunderstanding that there are different types of stem cells being studied for a variety of medical uses. Adult stem cells are the type being investigated for the treatment of autoimmune diseases such as lupus. To read more about stem cells, please visit the LFA’s Web site.

The LFA’s National Research Program: Bringing Down the Barriers™ is dedicated to addressing research issues that have for decades obstructed basic biomedical, clinical, epidemiological, behavioral, and translational lupus research. Using a three-pronged strategy, the LFA and its national network are committed accelerating the pace of lupus research by: directly funding research to close the gaps in lupus research; advocating for expanded investment in research from public and private sources; leading special initiatives and forging collaborative efforts among stakeholders to address critical issues to advancing the science and medicine of lupus.. For a complete list of grantees and additional information about the LFA National Research Program visit the LFA Web site at www.lupus.org.

About Lupus

Lupus is a chronic autoimmune disease in which the immune system is out of balance, causing inflammation and tissue damage to virtually any organ in the body. Lupus can be unpredictable and potentially fatal, yet no satisfactory treatment or cure exists. An estimated 1.5 million Americans and at least five million people worldwide have a form of lupus. Its health effects include heart attacks, strokes, seizures, miscarriages, and organ failure.

About the Lupus Foundation of America

The LFA is the foremost national nonprofit health organization dedicated to finding the causes of and cure for lupus, and providing support, services, and hope to all people affected by lupus. The LFA and national network of chapters, branches, and support groups conduct programs of research, education, and advocacy. For more information, visit www.lupus.org.

About the Wallace H. Coulter Foundation

Wallace Henry Coulter was an engineer, inventor, entrepreneur, and visionary. He was co-founder and Chairman of Coulter® Corporation, a worldwide medical diagnostics company, and through his discovery of the Coulter® Principle, is responsible for the current practice of hematology laboratory medicine.

Named for Coulter, the Foundation is dedicated to the advancement of translational research in biomedical engineering with the goal of accelerating the introduction of new technologies into patient care. The Foundation received its first funding in 1999 and since then has worked with colleges, universities, and professional associations that Wallace Coulter was associated with during his lifetime. His values of endless curiosity, continuous learning, teamwork, consideration, and respect for the individual, coupled with the highest level of ethics and integrity, are the cornerstone values of the Wallace H. Coulter Foundation.

Lupus Foundation of AmericaMaggie Maloney, 202-212-6766Maloney@lupus.orgorDuane Peters, 202-349-1145peters@lupus.org

Source: Lupus Foundation of America